About the Authors
- Sean Ekins
-
Contributed equally to this work with: Sean Ekins, Peter B. Madrid, Joel S. Freundlich
* E-mail: ekinssean@yahoo.com (SE); peter.madrid@sri.com (PBM); freundjs@rutgers.edu (JSF)
Affiliations Collaborative Drug Discovery Inc., 1633 Bayshore Highway, Suite 342, Burlingame, CA, 94010, United States of America, Collaborations in Chemistry, 5616 Hilltop Needmore Road, Fuquay-Varina, NC, 27526, United States of America
- Peter B. Madrid
-
Contributed equally to this work with: Sean Ekins, Peter B. Madrid, Joel S. Freundlich
* E-mail: ekinssean@yahoo.com (SE); peter.madrid@sri.com (PBM); freundjs@rutgers.edu (JSF)
Affiliation SRI International, 333 Ravenswood Avenue, Menlo Park, CA, 94025, United States of America
- Malabika Sarker
-
Affiliation SRI International, 333 Ravenswood Avenue, Menlo Park, CA, 94025, United States of America
- Shao-Gang Li
-
Affiliation Departments of Pharmacology & Physiology and Medicine, Center for Emerging and Reemerging Pathogens, Rutgers University–New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, United States of America
- Nisha Mittal
-
Affiliation Departments of Pharmacology & Physiology and Medicine, Center for Emerging and Reemerging Pathogens, Rutgers University–New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, United States of America
- Pradeep Kumar
-
Affiliation Department of Medicine, Center for Emerging and Reemerging Pathogens, Rutgers University–New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, United States of America
- Xin Wang
-
Affiliation Departments of Pharmacology & Physiology and Medicine, Center for Emerging and Reemerging Pathogens, Rutgers University–New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, United States of America
- Thomas P. Stratton
-
Affiliation Departments of Pharmacology & Physiology and Medicine, Center for Emerging and Reemerging Pathogens, Rutgers University–New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, United States of America
- Matthew Zimmerman
-
Affiliation Public Health Research Institute, Rutgers University–New Jersey Medical School, Newark, NJ, 07103, United States of America
- Carolyn Talcott
-
Affiliation SRI International, 333 Ravenswood Avenue, Menlo Park, CA, 94025, United States of America
- Pauline Bourbon
-
Affiliation SRI International, 333 Ravenswood Avenue, Menlo Park, CA, 94025, United States of America
- Mike Travers
-
Affiliation Collaborative Drug Discovery Inc., 1633 Bayshore Highway, Suite 342, Burlingame, CA, 94010, United States of America
- Maneesh Yadav
-
Affiliation SRI International, 333 Ravenswood Avenue, Menlo Park, CA, 94025, United States of America
- Joel S. Freundlich
-
Contributed equally to this work with: Sean Ekins, Peter B. Madrid, Joel S. Freundlich
* E-mail: ekinssean@yahoo.com (SE); peter.madrid@sri.com (PBM); freundjs@rutgers.edu (JSF)
Affiliation Departments of Pharmacology & Physiology and Medicine, Center for Emerging and Reemerging Pathogens, Rutgers University–New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, United States of America
Competing Interests
The authors have the following interests: Sean Ekins is a consultant for Collaborative Drug. Discovery Inc. and Collaborations in Chemistry. Sean Ekins has a pending provisional patent for Anti-Chagas therapy and compositions # 62/170,518. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SE PBM MS PK CT JSF. Performed the experiments: SE PBM MS PK S-GL NM XW TPS CT PB MT JSF MZ. Analyzed the data: SE PBM MS PK JSF. Contributed reagents/materials/analysis tools: SE PBM MS PK CT JSF. Wrote the paper: SE PBM MS PK CT MY JSF.